Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cardiovascular Research

• Publication date

  2003-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0008-6363(02)00663-6PMID 12566112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human Relaxin Gene 3 (H3) and the Equivalent Mouse Relaxin (M3) Gene

  2002cited by this paper
• Is the Pregnancy Hormone Relaxin Also a Vasodilator Peptide Secreted by the Heart?

  2002cited by this paper
• Up-Regulation of Mesotocin Receptors in the Tammar Wallaby Myometrium Is Pregnancy-Specific and Independent of Estrogen1

  2002cited by this paper
• Relaxin up‐regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells

  2002cited by this paper
• Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.

  2001cited by this paper
• The pregnancy hormone relaxin is a player in human heart failure

  2001cited by this paper
• Relaxin knockout mice demonstrate delayed growth and have underdeveloped male reproductive tracts

  2001cited by this paper
• Inotropic Stimulation Induces Cardiac Dysfunction in Transgenic Mice Expressing a Troponin T (I79N) Mutation Linked to Familial Hypertrophic Cardiomyopathy*

  2001cited by this paper
• Sex differences in cardiomyopathy phenotype in mice overexpressing β2-adrenoceptors in the heart

  2001cited by this paper
• Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivo

  2001cited by this paper
• Collagen Studies in Late Pregnant Relaxin Null Mice1

  2000cited by this paper
• Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats.

  2000cited by this paper
• Sex-related survival differences in murine cardiomyopathy are associated with differences in TNF-receptor expression.

  2000cited by this paper
• Serial echocardiographic assessment of left ventricular dimensions and function after myocardial infarction in mice.

  2000cited by this paper
• beta(2)-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis.

  2000cited by this paper
• Mice without a functional relaxin gene are unable to deliver milk to their pups.

  1999cited by this paper
• Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment

  1999cited by this paper
• Relaxin protects against myocardial injury caused by ischemia and reperfusion in rat heart.

  1998cited by this paper
• Effects of relaxin, pregnancy and parturition on collagen metabolism in the rat pubic symphysis.

  1998cited by this paper
• Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice.

  1998cited by this paper
• Relaxin stimulates atrial natriuretic peptide secretion in perfused rat heart.

  1996cited by this paper
• Relaxin induces an extracellular matrix-degrading phenotype in human lung fibroblasts in vitro and inhibits lung fibrosis in a murine model in vivo.

  1996cited by this paper
• The effect of relaxin on collagen metabolism in the nonpregnant rat pubic symphysis: the influence of estrogen and progesterone in regulating relaxin activity.

  1996cited by this paper
• A Mouse Model of Familial Hypertrophic Cardiomyopathy

  1996cited by this paper
• Modulation of particulate nitric oxide synthase activity and peroxynitrite synthesis in cholesterol enriched endothelial cell membranes.

  1995cited by this paper
• Relaxin‐induced increased coronary flow through stimulation of nitric oxide production

  1995cited by this paper
• Mineralocorticoids, hypertension, and cardiac fibrosis.

  1994cited by this paper
• Brain angiotensin-II partially mediates the effects of relaxin on vasopressin and oxytocin release in anesthetized rats.

  1994cited by this paper
• Human relaxins: chemistry and biology.

  1994cited by this paper
• Evidence for a novel source of relaxin: atrial cardiocytes.

  1994cited by this paper
• The mouse relaxin gene: nucleotide sequence and expression.

  1993cited by this paper
• Expression of relaxin mRNA and relaxin receptors in postnatal and adult rat brains and hearts. Localization and developmental patterns.

  1993cited by this paper
• The purely chronotropic effects of relaxin in the rat isolated heart

  1993cited by this paper
• Cardiac effects of relaxin in rats.

  1992cited by this paper
• Mechanism of the Haemotensive Action of Porcine Relaxin in Anaesthetized Rats

  1990cited by this paper
• Relaxin modulates synthesis and secretion of procollagenase and collagen by human dermal fibroblasts.

  1990cited by this paper
• Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography. Part II. Clinical studies.

  1989cited by this paper
• Subsistence crop deficit and family structure in Sub-Saharan Africa.

  1947cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society Relaxin Increases Secretion of Matrix Metalloproteinase- 2 and Matrix Metalloproteinase-9 during Uterine and Cervical Growth and Remodeling in the Pig

  year unknowncited by this paper

• Nonylphenol Exposure and Cardiovascular Toxicity: Mechanistic Insights and Integrated Risk Assessment from Experimental Models.

  2025cites this paper
• The impact of aging and biological sex on cardiac collagen metabolism.

  2025cites this paper
• Cardiomyocyte-specific RXFP1 overexpression protects against pressure overload-induced cardiac dysfunction independently of Relaxin.

  2024cites this paper
• Relaxin suppresses atrial fibrillation, reverses fibrosis and reduces inflammation in aged hearts.

  2024cites this paper
• Relaxin/serelaxin for cardiac dysfunction and heart failure in hypertension.

  2022cites this paper
• Relaxin abrogates genomic remodeling of the aged heart.

  2021cites this paper
• Relaxin Attenuates Organ Fibrosis via an Angiotensin Type 2 Receptor Mechanism in Aged Hypertensive Female Rats

  2021cites this paper
• Extracellular Matrix Protein Ratios in the Human Heart and Vessels: How to Distinguish Pathological From Physiological Changes?

  2021cites this paper
• The effect of nutraceuticals on multiple signaling pathways in cardiac fibrosis injury and repair

  2020cites this paper
• Treatment with a DC-SIGN ligand reduces macrophage polarization and diastolic dysfunction in the aging female but not male mouse hearts

  2020cites this paper
• Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways.

  2019cites this paper
• Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials.

  2019cites this paper
• Muscle Gene Therapy

  2019influential citation
• Considerations on Preclinical Neuromuscular Disease Gene Therapy Studies

  2019cites this paper
• Human Relaxin‐2 Fusion Protein Treatment Prevents and Reverses Isoproterenol‐Induced Hypertrophy and Fibrosis in Mouse Heart

  2019cites this paper
• Relaxin and fibrosis: Emerging targets, challenges, and future directions.

  2019cites this paper
• Circulating Relaxin-1 Level Is a Surrogate Marker of Myocardial Fibrosis in HFrEF

  2019cites this paper
• The Influence of Sex on Cardiac Physiology and Cardiovascular Diseases

  2019cites this paper
• Cardiac Fibroblast to Myofibroblast Phenotype Conversion—An Unexploited Therapeutic Target

  2019cites this paper
• Effect of the peptides Relaxin, Neuregulin, Ghrelin and Glucagon‐like peptide‐1, on cardiomyocyte factors involved in the molecular mechanisms leading to diastolic dysfunction and/or heart failure with preserved ejection fraction

  2019cites this paper
• Transforming growth factor β (TGFβ) and related molecules in chronic kidney disease (CKD).

  2019cites this paper
• Cardioprotective actions of relaxin.

  2019cites this paper
• Relaxin Family Member Insulin‐Like Peptide 6 Ameliorates Cardiac Fibrosis and Prevents Cardiac Remodeling in Murine Heart Failure Models

  2018cites this paper
• Abnormal extracellular matrix remodelling in the cervix of pregnant relaxin-deficient mice is not associated with reduced matrix metalloproteinase expression or activity.

  2018cites this paper
• Targeting the Relaxin Pathway for Liver Disease Treatment.

  2018cites this paper
• Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis

  2017cites this paper
• Synthesis of recombinant human relaxin H2 in bacteria and its effects on differentiation of carcinoembryonic stem cells

  2017cites this paper
• Novel Anti-fibrotic Therapies

  2017cites this paper
• The actions of relaxin on the human cardiovascular system

  2017cites this paper
• Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial–Mesenchymal Transition

  2017cites this paper
• Anti‐fibrotic actions of relaxin

  2017cites this paper
• Vascular actions of relaxin: nitric oxide and beyond

  2017cites this paper
• Relaxin Inhibits Cardiac Fibrosis in Diabetic Rats: Roles of Protein Kinase Cδ.

  2017cites this paper
• Relaxin contributes to the regulation of arterial pressure in adult female mice.

  2017cites this paper
• Serelaxin: A Novel Therapeutic for Vascular Diseases.

  2016cites this paper
• Mesenchymal stromal cells targeting kidney disease: Benefits of a combined therapeutic approach

  2016cites this paper
• Vasoprotective actions of relaxin in the vascular system

  2016cites this paper
• The vasoprotective properties of relaxin in the peripheral vasculature of males

  2016cites this paper
• Human relaxin gene expression delivered by bioreducible dendrimer polymer for post-infarct cardiac remodeling in rats.

  2016cites this paper
• Does serelaxin treatment alter passive mechanical wall properties in small resistance arteries?

  2016cites this paper
• H2 relaxin expression and its effect on clinical outcomes in patients with chronic heart failure.

  2015cites this paper
• Myocardium in a dish : the influence of cellular and extracellular perturbations on cardiomyocyte contractility

  2015cites this paper
• The impact of diabetes on left ventricular diastolic function in patients with arterial hypertension

  2015cites this paper
• Role of sphingosine kinase/S1P axis in ECM remodeling of cardiac cells elicited by relaxin.

  2015cites this paper
• Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein

  2014cites this paper
• Gender and Cardiovascular Disease in the Post-Genomic Era

  2014cites this paper
• Role of biological sex in normal cardiac function and in its disease outcome - a review.

  2014cites this paper
• Relaxin Does Not Improve Angiotensin II-Induced Target-Organ Damage

  2014cites this paper
• Relaxin inhibit cardiac fibrosis induced by phorbol 12-myristate 13-acetate.

  2014cites this paper
• A Vasoactive Role for Endogenous Relaxin in Mesenteric Arteries of Male Mice

  2014cites this paper
• DOTTORATO DI RICERCA IN SCIENZE BIOMEDICHE, INDIRIZZO IN MORFOLOGIA E MORFOGENESI UMANA

  2014cites this paper
• Relaxin decreases the severity of established hepatic fibrosis in mice

  2014cites this paper
• The role of relaxin in left ventricular fibrosis: Endogenous expression and therapeutic potential

  2014cites this paper
• The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.

  2013cites this paper
• Nitric oxide synthases and heart failure - lessons from genetically manipulated mice.

  2013cites this paper
• Relaxin Suppresses Atrial Fibrillation by Reversing Fibrosis and Myocyte Hypertrophy and Increasing Conduction Velocity and Sodium Current in Spontaneously Hypertensive Rat Hearts

  2013cites this paper
• Relaxin, cardiac stem cells and heart regeneration.

  2013cites this paper
• Enhanced Uterine Artery Stiffness in Aged Pregnant Relaxin Mutant Mice Is Reversed with Exogenous Relaxin Treatment1

  2013cites this paper
• Relaxin family peptides and their receptors.

  2013cites this paper
• Relaxin Prevents Cardiac Fibroblast-Myofibroblast Transition via Notch-1-Mediated Inhibition of TGF-β/Smad3 Signaling

  2013cites this paper
• Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes.

  2012cites this paper
• Relaxin and castration in male mice protect from, but testosterone exacerbates, age-related cardiac and renal fibrosis, whereas estrogens are an independent determinant of organ size.

  2012influential citation
• The Formation and Stabilization of a Novel G-Quadruplex in the 5′-Flanking Region of the Relaxin Gene

  2012cites this paper
• Serum Relaxin Levels and Importance in Systemic Sclerosis Patients

  2012cites this paper
• Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action.

  2012cites this paper
• Investigating the significance of relaxin in experimental diabetic renal disease

  2011influential citation
• Relaxin remodels fibrotic healing following myocardial infarction

  2011cites this paper
• Relaxin regulates vascular wall remodeling and passive mechanical properties in mice.

  2011cites this paper
• Detected Atrial Arrhythmias with the 12-lead Holter System in Patients Complaining of Palpitations with Normal 12-lead ECGs - Gender and Age Differences

  2011cites this paper
• Relaxin as a cardiovascular drug: a promise kept.

  2011cites this paper
• Relaxin inhibits early steps in vascular inflammation.

  2011cites this paper
• 11β-hydroxysteroid dehydrogenase type 1 : a new therapeutic target post-myocardial infarction?

  2010cites this paper
• Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

  2010cites this paper
• Cardiovascular effects of relaxin: from basic science to clinical therapy

  2010cites this paper
• Spontaneous development of left ventricular hypertrophy and diastolic dysfunction in mice lacking all nitric oxide synthases.

  2010cites this paper
• Influence of Sex Hormones and Phytoestrogens on Heart Disease in Men and Women

  2010cites this paper
• Novel neurohormonal insights with therapeutic potential in chronic heart failure.

  2010cites this paper
• Relaxin Therapy Reverses Large Artery Remodeling and Improves Arterial Compliance in Senescent Spontaneously Hypertensive Rats

  2010cites this paper
• Membrane receptors: structure and function of the relaxin family peptide receptors.

  2010cites this paper
• Relaxin and its role in the development and treatment of fibrosis.

  2009cites this paper
• Measuring Cardiac Function

  2009cites this paper
• Sex-based cardiac physiology.

  2009cites this paper
• Clinical profile of relaxin, a possible new drug for human use.

  2009cites this paper
• Iatrogenic, Transgenic, and Naturally Occurring Models of Cardiomyopathy and Heart Failure

  2009cites this paper
• Reversal of Cardiac Fibrosis and Related Dysfunction by Relaxin

  2009cites this paper
• Arginase II Knockout Mouse Displays a Hypertensive Phenotype Despite a Decreased Vasoconstrictory Profile

  2009cites this paper
• Circulating levels of relaxin and its relation to cardiovascular function in patients with hypertension

  2009cites this paper
• RELAXIN REGULATES SYSTEMIC HEMODYNAMICS AND ARTERIAL WALL MECHANICAL PROPERTIES

  2008cites this paper
• Relaxin family peptide receptors--from orphans to therapeutic targets.

  2008cites this paper
• Relaxin family peptide receptor 3- RXFP3 (GPCR135)

  2008cites this paper
• Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.

  2008cites this paper
• Adenovirus-mediated delivery of relaxin reverses cardiac fibrosis.

  2008cites this paper
• Human cardiac-specific cDNA array for idiopathic dilated cardiomyopathy: sex-related differences.

  2008cites this paper
• The effects of biological sex and diet on the development of heart failure.

  2007cites this paper
• Improved chemical synthesis and demonstration of the relaxin receptor binding affinity and biological activity of mouse relaxin.

  2007cites this paper
• Drugs of the future: the hormone relaxin

  2007cites this paper
• Au th or ' s pe rs on al co py Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension

  2007cites this paper
• Doppler Ultrasound in Mice

  2007cites this paper
• The effects of relaxin on extracellular matrix remodeling in health and fibrotic disease.

  2007cites this paper
• Relaxin receptors in hepatic stellate cells and cirrhotic liver.

  2007cites this paper